がん看護実践シリーズ　11　悪性リンパ腫・白血病

出版社： メヂカルフレンド社
著者：
発行日： 2007-11-15
分野： 看護学  >  臨床/成人/老人
ISBN： 9784839214210
電子書籍版： 2007-11-15 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

2,750 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,750 円(税込)

購入する

商品紹介

がん患者の看護に不可欠な知識を完全収載。基本的な知識から最新の知見まで、臨床の今を反映した内容。臓器別がんの検査・診断・治療の今と、その看護がわかる。安全・安楽な看護、根拠のある看護実践のための情報を整理し収載。若手看護師の知識不足、経験不足を補い、臨床での自身につなげる。

目次

  • がん看護実践シリーズ　11　悪性リンパ腫・白血病

    ―目次―

    第１編　悪性リンパ腫患者の看護
    第１章　悪性リンパ腫の特徴についての理解
    第２章　悪性リンパ腫の診断・治療・看護
    第３章　患者の自立・社会復帰のためのチーム医療の展開
    第４章　ターミナル期にある患者の支援

    第２編　白血病患者の看護
    第１章　白血病の特徴についての理解
    第２章　白血病の診断・治療・看護
    第３章　患者の自立・社会復帰のためのチーム医療の展開
    第４章　ターミナル期にある患者の支援

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1編 悪性リンパ腫患者の看護

P.20 掲載の参考文献
1) Marugame T, et al:Cancer Incidence and Incidence Rates in Japan in 2000, Jpn J Clin Oncol, 36 (10):668-675, 2006.
PubMed
2) Wintrobe's Clinical Hematology, 11:2366.
 
3) Rosdahl N, et al:Hodgkin's Disease in patients with previous mononucleosis, BMJ, 2:253-256, 1974.
PubMed
4) Lyter DW, et al:Incidence of human immunodeficiency virus-related and non-related malignancies in a large cohort of homosexual men, J Clin Oncol, 13:2540-2546, 1995.
 
P.63 掲載の参考文献
1) DeVita VT Jr, Hubbard SM:Hodgkin's disease, N Engl J Med, 328:560-565,1993.
PubMed
2) Bonadonna G, et al:Combination chemotherapy of Hodgkin's disease with adriamycin, bloemycin, vinblastine, and imidazole carboximide versus MOPP, Cancer, 36:252-259, 1975.
 
3) Canellos GP, et al:Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med, 327:1478-1484, 1992.
 
4) Santoro J, et al:Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease; superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy, J Clin Oncol, 5:27-37, 1987.
 
5) Diehl V, et al:Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease, N Engl J Med, 348:2386-2395,2003.
PubMed
6) Josting A, et al:Secondary myeloid leukemia and myelodysplastic syndromes inpatients treated for Hodgkin's disease; a report from the German Hodgkin's lymphoma Study Group, J Clin Oncol, 21:3440-3446, 2003.
 
7) Marcus R, et al:CVP chemotherapy plus rituximab compared with CVP as first line treatment for advanced follicular lymphoma, Blood, 105:1417-1423, 2005.
PubMed
8) Hiddemann W, et al:Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone; results of a prospective randomized study of the German Low-Grade Lymphoma Study Group, Blood, 106:3725-3732, 2005.
 
9) Fisher RI, et al:Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma, N Engl J Med, 328:1002-1006, 1993.
PubMed
10) Coiffier B, et al:CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma, N Engl J Med, 346:235-242, 2002.
PubMed
11) McLaughlin P, et al:Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma; half of patients respond to a four-dose treatment program, J Clin Oncol, 16:2825-2833, 1998.
 
12) Kaminski MS, et al:131I-tositumomab therapy as initial treatment for follicular lymphoma, N Engl J Med, 352:441-449, 2005.
PubMed
13) Lyman GH:Guidelines of the National Comprehensive Cancer Network on theuse of myeloid growth factors with cancer chemotherapy;a review of the evidence, J Natl Compr Canc Netw, 3:557-571, 2005.
 
14) Gregory SA, Trumper L:Chemotherapy dose intensity in non-Hodgkin's lymphoma;is dose intensity an emerging paradigm for better outcomes? Ann Oncol, 16:1413-1424, 2005.
PubMed
15) Bohlius J, et al:Impact of granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF in patients with malignant lymphoma; a systematic review, Br J Haematol, 122:413-423, 2003.
PubMed
16) Del Toro G, et al:Tumor lysis syndrome:pathophysiology, definition, and alternative treatment approaches, Clin Adv Hematol Oncol, 3:54-61, 2005.
PubMed
17) Cairo MS, Bishop M:Tumour lysis syndrome; new therapeutic strategies and classification, Br J Haematol, 127:3-11, 2004.
PubMed
18) Horning SJ, et al:Very brief (8 week) chemotherapy (CT) and low dose (30Gy) radiotherapy (RT) for limited stage Hodgkin's disease (HD); preliminary results of the Stanford-Kaiser G4 study of Stanford V+RT, Blood, 94:1717a, 1999.
 
19) Sieber M, et al:Two cycles ABVD plus extended field radiotherapy is superior to radiotherapy alone in early stage Hodgkin's disease; Results of the German Hodgkin's Lymphoma Study Group (GHSG) Trial HD7, Blood, 100:341a, 2002.
 
20) Specht L, et al:Influence of more extensive radiotherapy and adjuvant chemotherapy on long-term outcome of early-stage Hodgkin's disease; a meta-analysis of 23 randomized trials involving 3888 patients. International Hodgkin's Disease Collaborative Group, J Clin Oncol, 16:830-843, 1998.
 
21) Engert A, et al:Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patient swith early-stage unfavorable Hodgkin's lymphoma. Results of the HD8 trial of the German Hodgkin's Lymphoma Study Group, J Clin Oncol, 21:3601-3608, 2003.
 
22) Aleman BM, et al:Involved-field radiotherapy for advanced Hodgkin's lymphoma, N Eng J Med, 348:2396-2406, 2003.
 
23) Raemaekers J, et al:Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy; interim results from the ongoing EORTC-LCG and GPMC phase III trial, Ann Oncol, 8 (Suppl 1):111 4 (P2/122), 1997.
 
24) Miller T, et al:Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate and high-grade non-Hodgkin's lymphoma, N Engl J Med, 339:21-26, 1998.
PubMed
25) Constine LS, et al:Cardiac function, perfusion, and morbidity in irradiated long-term survivors of Hodgkin's disease, Int J Radiat Oncol Biol Phys, 39:897-906. 1997.
PubMed
26) Dores GM, et al:Secondary malignant neoplasms among long-term survivors of Hodgkin's disease; a population-based evaluation over 25 years, J Clin Oncol, 20:3484-3494, 2002.
 
27) Longo DL, et al:Conventional-dose salvage combination chemotherapy inpatients relapsing with Hodgkin's disease after combination chemotherapy; the low probability for cure, J Clin Oncol, 15:528-534, 1997.
 
28) Bonfante V, et al:Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD. J Clin Oncol, 15:528-534, 1997.
PubMed
29) Ferme C, et al:Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy; results of the Group d:Etudes des Lymphomes de l:Adulte H89 Trial, J Clin Oncol, 20:467-475, 2002.
 
30) Reece DE, et al:High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV±P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy, Blood, 86:451-456, 1995.
 
31) Peggs KS, et al:Clinical evidence of a graft-versus-Hodgkin's-lymphoma effect after reduced-intensity allogeneic transplantation, Lancet. 2005, 1934-41, 2005.
PubMed
32) Philip T, et al:Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma, N Engl J Med, 333:1540-1545, 1995.
PubMed
33) Vaso MT, et al:In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma, Br J Haematol, 109:729-735, 2000.
 
34) Magni M, et al:Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma; evidence for a role of both chemotherapy and rituximab infusion, Blood, 96:864-869, 2000.
PubMed
35) Laport GG:The role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma, Biol Blood Marrow Transplant, 12:59-65, 2006.
PubMed
36) Laport GG:The role of hematopoietic cell transplantation for follicular non-Hodgkin's lymphoma, Biol Blood Marrow Transplant, 12:59-65, 2006.
PubMed
37) Ng AK, Mauch PM:Late complications of therapy of Hodgkin's disease; prevention and management, Curr Hematol Rep, ;3:27-33, 2004.
PubMed
38) Kornblith AB, et al:Hodgkin's disease survivors at increased risk for problems in psychosocial adaptation, The Cancer and Leukemia Group B, Cancer, 70:2214-2224, 1992.
 
39) Loge JH, et al:Fatigue and psychiatric morbidity among Hodgkin's disease survivors, J Pain Symptom Manage, 19:91-99, 2000.
 
40) Loge JH, et al:Hodgkin's disease survivors more fatigues than the general population, J Clin Oncol, 17:253-261, 1999.
 
P.74 掲載の参考文献
1) 畠清彦, 他:悪性リンパ腫の診断･治療･看護, がん看護, 11 (1):6-67, 2006.
 
2) 西條長宏, 渡辺孝子編:がん化学療法看護, がん看護, 11 (2), 2006.
 
3) 狩野太郎, 神田清子:化学療法を受ける非ホジキン悪性リンパ腫患者の看護, ナーシングカレッジ, 9 (13):56-63, 2005.
 
4) 狩野太郎, 神田清子:化学療法を受ける悪性リンパ腫患者の看護, ナーシングカレッジ, 9 (13):53-55, 2005.
Medical*Online
5) 神田清子, 狩野太郎:悪性リンパ腫;基礎知識, ナーシングカレッジ, 9 (13):46-52, 2005.
 
6) 本山清美:外来でがん化学療法を受けている患者と家族の教育的支援, がん看護, 9 (4):310-312, 2004.
 
7) 後藤明美:各種術前検査における外来看護, がん看護, 11 (6):655-657, 2006.
 
8) 澤田裕久:がんのPET-CT検査, 月刊ナーシング, 25 (10):102-110, 2005.
 
9) 竹田津文俊, 伊藤正子監:血液・造血器疾患<Nursing Selection 5>, 学習研究社, 2006.
 
10) 堀田知光, 横田弘子:血液・造血器疾患の治療と看護, 南江堂, 2004.
 

第2編 白血病患者の看護

P.134 掲載の参考文献
1) Prarkin et al:Cancer Incidence in Five Continents. Vol.8, IARC Scientific Publications No.155, IARC Press, 2002.
 
2) Greer et al:Wintrobe's clinical hematology 11th, Lippincott Williams & Wilkins, 2004.
 
3) Blume et al:Thomas's Hematopoietic Cell Transplantation third edition. Blackwell publishing, 2004.
 
4) 横井麻珠美:白血病外来での看護;治療開始まで, および外来治療フォロー, がん看護, 11 (3):381-384, 2006.
 
5) 野崎千里:白血病化学療法時の支持療法の看護【1】感染対策;感染予防･対処, がん看護, 11 (3):392-397, 2006.
 
6) 野崎千里:白血病化学療法時の支持療法の看護【3】貧血･血小板減少時の看護, がん看護, 11 (3):401-402, 2006.
 
7) 五月女隆:白血病治療後の経過観察, がん看護, 11 (3):412-413, 2006.
 
8) 藤木由佳子:白血病の看護;セルフケア能力を高めるケア, がん看護, 11 (3):417-419, 2006.
 
9) 季羽倭文子, 他監:がん看護学;ベッドサイドから在宅ケアまで, 三輪書店, 2004, p.33-39.
 
10) 鈴木優子:悪性リンパ腫の放射線療法看護, がん看護, 11 (1):60-64, 2006.
 

書評

最近チェックした商品履歴

Loading...